Physician profile
Jonathan D Dubin
NPI 1356300222
$7,579.68
in general payments reported to CMS, 2019-2025
30 companies · $605 in 2025
The $605 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,821 · 2020: $410 · 2021: $870 · 2022: $833 · 2023: $885 · 2024: $1,155 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,630 · Travel and Lodging: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,629.73 |
| Travel and Lodging | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,950.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $909.83 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $809.04 | 2019-2024 | Xarelto |
| Pfizer INC. | $419.46 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $376.85 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $338.12 | 2019-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $337.96 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $334.73 | 2021-2025 | Onpattro, Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.95 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $295.60 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Sanofi-Aventis U.S. LLC | $241.90 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $193.44 | 2021-2024 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $177.29 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $173.26 | 2022-2024 | Azure Xt Dr Mri Surescan |
| Amarin Pharma, INC. | $104.21 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $100.00 | 2023 | Primescan Connect |
| Boston Scientific Corporation | $77.39 | 2021-2023 | Watchman Access System, Watchman |
| Amgen INC. | $65.85 | 2019-2023 | Repatha |
| Scpharmaceuticals INC. | $49.97 | 2024-2025 | |
| Atricure, INC. | $46.74 | 2023-2024 | |
| Akcea Therapeutics, INC. | $42.79 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $36.24 | 2023 | Assure Wcd |
| Medicomp INC | $35.23 | 2024 | Telepatch Cardiac Monitor |
| Esperion Therapeutics, INC. | $33.97 | 2020-2021 | |
| Cleerly, INC. | $29.35 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Inspire Medical Systems, INC. | $24.84 | 2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $21.19 | 2025 | |
| Lantheus Medical Imaging, INC. | $18.50 | 2020 | |
| Amryt Pharma Holdings LTD | $18.25 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.